Breast cancer survivors may dodge diabetes with common diabetes drug

NCT ID NCT06763328

First seen Jan 31, 2026 · Last updated Apr 29, 2026 · Updated 8 times

Summary

This study looks at whether the diabetes drug metformin can help women with stage I-III breast cancer who have finished chemotherapy avoid or reverse insulin resistance, a condition that can lead to diabetes and heart disease. About 200 women will either get metformin plus standard diet and exercise advice, or standard advice alone. The goal is to see if metformin helps keep blood sugar levels normal over two years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • City of Hope Medical Center

    RECRUITING

    Duarte, California, 91010, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • UC San Diego Moores Cancer Center

    NOT_YET_RECRUITING

    La Jolla, California, 92093, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of California-Riverside

    NOT_YET_RECRUITING

    Riverside, California, 92521, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.